Nanopharm’s SmartTrack: Accelerating OINDP Respiratory Drug Delivery
Revolutionize your OINDP respiratory drug delivery with Nanopharm’s SmartTrack. Accelerate development and mitigate risks through expert formulation and integrated solutions. Your pathway to success starts here.
Nanopharm’s Innovations in Nasal Drug Delivery of Biologics
Discover Nanopharm’s pioneering work in nasal drug delivery of biologics. Learn how their research is shaping drug development against SARS-CoV-2.
Conversations with Dr Julie Suman, on Nasal Drug Delivery: Current trends, technical challenges and opportunities for therapeutic innovation
Aptar Pharma present data on the challenges and opportunities for Nasal drug delivery.
Fundamental properties of propellant aerosols can guide transition to low global warming potential pMDIs: size, velocity and surface charge
Discover Nanopharm’s groundbreaking research on Low GWP propellants in pMDIs. Learn how they revolutionize drug delivery and the role of valve and actuators.
Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
Understand how particle size impacts inhalation drug delivery and the role of dry powder inhalers (DPIs) in treating respiratory diseases.
Characterizing Nasal Suspensions for Regulatory and Scientific Purposes
Explore Nanopharm’s in-depth research on particle size and its role in in vitro bioequivalence for nasal drug delivery. Discover how particle sizing impacts regulatory compliance and drug efficacy.
